Related Experiment Video
Updated: May 21, 2026
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
The role of platelets in the pathogenesis of systemic sclerosis
Giuseppe A Ramirez1, Stefano Franchini, Patrizia Rovere-Querini
1Department of Immunology, San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
Insights
Platelets are activated in systemic sclerosis (SSc), contributing to fibrosis and vascular issues. Understanding this role is key for developing new SSc treatments.
Area of Science:
- Immunology
- Rheumatology
- Vascular Biology
Background:
- Systemic sclerosis (SSc) is an inflammatory disease causing organ damage via fibrosis and ischemia.
- The exact cause of SSc is unknown, hindering effective treatment development.
- Platelets play a role in inflammation, immunity, and cell proliferation, making them relevant to SSc.
Purpose of the Study:
- To investigate the role of platelets in the pathogenesis of Systemic Sclerosis.
- To understand how platelet activation contributes to SSc characteristics.
Main Methods:
- The study focuses on the observed activated state of platelets in SSc patients.
- Analysis of the link between activated platelets, endothelial injury, and immune system activation in SSc.
Main Results:
- Platelets in SSc patients exhibit a persistent activated state.
- This activation is associated with endothelial injury and immune system activation.
- Activated platelets release compounds that promote SSc-related fibrosis and impaired vascular tone.
Conclusions:
- Platelets are significant contributors to Systemic Sclerosis pathogenesis.
- Targeting platelet activation may offer a novel therapeutic strategy for SSc.
- Further research into platelet function in SSc is warranted.
Abstract:
Systemic sclerosis (SSc) is an inflammatory disease of unknown etiology characterized by widespread organ dysfunction due to fibrosis and ischemia. Its nebulous pathogenic background and the consequent absence of an etiological therapy prevent the adoption of satisfying treatment strategies, able to improve patients' quality of life and survival and stimulate researchers to identify a unifying pathogenic target. Platelets show a unique biological behavior, lying at the crossroads between vascular function, innate and adaptive immunity, and regulation of cell proliferation. Consequently they are also emerging players in the pathogenesis of many inflammatory diseases, including SSc. In the setting of SSc platelets are detectable in a persistent activated state, which is intimately linked to the concomitant presence of an injured endothelium and to the widespread activation of the innate and adaptive immune system. As a consistent circulating source of bioactive compounds platelets contribute to the development of many characteristic phenomena of SSc, such as fibrosis and impaired vascular tone.
Related Concept Videos
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:30Atherosclerosis I: Introduction
01:16Clot Retraction and Fibrinolysis
01:26Coronary Artery Disease II: Pathophysiology
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...